How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study

MLA

C Cottron, et al. “How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study.” Journal of Crohn’scolitis, vol. 16, no. 8, Dec. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....51a19303dcea0e37e1d4e477cd9778e6&authtype=sso&custid=ns315887.

APA

C Cottron, X Treton, R Altwegg, C Reenaers, A Amiot, M Fumery, L Vuitton, L Peyrin-Biroulet, G Bouguen, O Dewit, S Nancey, L Caillo, X Roblin, M Beylot-Barry, P Rivière, & D Laharie. (2021). How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study. Journal of Crohn’scolitis, 16(8).

Chicago

C Cottron, X Treton, R Altwegg, C Reenaers, A Amiot, M Fumery, L Vuitton, et al. 2021. “How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study.” Journal of Crohn’scolitis 16 (8). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....51a19303dcea0e37e1d4e477cd9778e6&authtype=sso&custid=ns315887.